IBD-related symptoms by type of hormonal contraceptive type in current and past users. Participants reporting different current and previous hormonal methods are counted for each method; therefore, the total n = number of contraceptive method exposures. DMPA, depot medroxyprogesterone acetate; implant, etonogestrel subdermal implant; LNG IUD, levonorgestrel intrauterine device; POP, progestin-only pills; P/P/R, combination estrogen and progestin pills, transdermal patch, or vaginal ring.